Floapt-D Tablet MR is a combination medication containing Tamsulosin 0.4mg and Dutasteride 0.5mg, primarily prescribed for the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland causing urinary difficulties. Tamsulosin is an alpha-1 adrenergic receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms such as difficulty in starting urination, weak stream, and frequent urination. Dutasteride is a 5-alpha-reductase inhibitor that reduces the production of dihydrotestosterone (DHT), a hormone responsible for prostate growth, helping to shrink the enlarged prostate over time and prevent further progression of BPH. The modified-release (MR) formulation ensures a gradual release of the active ingredients, maintaining steady blood levels and enhancing therapeutic efficacy while minimizing side effects. Floapt-D is typically administered once daily and should be taken as directed by a healthcare professional. Common side effects may include dizziness, headache, or ejaculation disorders, and patients should be monitored for any adverse reactions. This combination therapy offers a dual mechanism approach, addressing both the symptoms and underlying causes of BPH, improving quality of life for affected individuals.